Maturitas: Volume 131 to Volume 142
Maturitas is the official journal of the European Menopause and Andropause Society (EMAS) and is affiliated with the Australasian Menopause Society (AMS).
It is an international, multidisciplinary, peer-reviewed scientific journal focused on midlife health and beyond. The journal publishes original research, reviews, consensus statements, guidelines, and mini-reviews covering various aspects of postreproductive health in both genders, spanning from basic science to health and social care.
The topics covered by Maturitas include aging, alternative and complementary medicines, arthritis and bone health, cancer, cardiovascular health, cognitive and physical functioning, epidemiology, health and social care, gynecology/endocrinology, nutrition/obesity diabetes/metabolic syndrome, menopause, ovarian aging, mental health, pharmacology, sexuality, and quality of life.
The journal serves as a platform for researchers, clinicians, and care providers to exchange new insights and developments in the field of midlife health, with a focus on promoting a personalized approach to healthy aging.
Maturitas offers a Fast Track publication option for clinical trials and research articles with groundbreaking results that warrant rapid dissemination. Articles accepted through this route can expect a final editorial decision in under 7 weeks, and accepted articles are published online (as Articles-in-Press) in less than 5 weeks.
The journal has a significant electronic readership, with an average of over 60,000 full-text articles downloaded from ScienceDirect each month in 2021.
Volume 131: Pages 1-102 (January 2020)
Volume 132: Pages 1-80 (February 2020)
Volume 133: Pages 1-70 (March 2020)
Volume 134: Pages 1-62 (April 2020)
Volume 135: Pages 1-88 (May 2020)
Volume 136: Pages 1-60 (June 2020)
Volume 137: Pages 1-64 (July 2020)
Volume 138: Pages 1-82 (August 2020)
Volume 139: Pages 1-100 (September 2020)
Volume 140: Pages 1-84 (October 2020)
Volume 141: Pages 1-88 (November 2020)
Volume 142: Pages 1-74 (December 2020)
Reviews
There are no reviews yet.